Belatacept - Bristol-Myers Squibb
At a glance
- Drug Originator Bristol-Myers Squibb
- Drug Class Antirheumatics; Immunoglobulin fusion proteins; Recombinant fusion proteins
- Mechanism of Action CD80 antigen inhibitors; T cell activation inhibitors
- USA Patent Applicants BRISTOL MYERS SQUIBB
- USA Patents 37
- BLAs 1
- International Patents 377
Disclaimer